bioRxivGenomicsPreprint
Exploring the genetic and epigenetic underpinnings of early-onset cancers: Variant prioritization for long read whole genome sequencing from family cancer pedigrees
Melissa KrameriD, Sara GoodwiniD, Robert L. Wappel, Matilde BorioiD, Kenneth OffitiD, Darren Richard FeldmaniD, Zsofia Kinga StadleriD, William Richard McCombieiD
Abstract
Despite significant advances in our understanding of genetic cancer susceptibility, known inherited cancer predisposition syndromes explain at most 20% of early-onset cancers. As early-onset cancer prevalence continues to increase, the need to assess previously inaccessible areas of the human genome, harnessing a trio or quad family-based architecture for variant filtration, may reveal further insights into cancer susceptibility. To assess a broader spectrum of variation than can be ascertained by multi-gene panel sequencing, or even whole genome sequencing with short reads, we employed long read whole genome sequencing using an Oxford Nanopore Technology (ONT) PromethION of 3 families containing an early-onset cancer proband using a trio or quad family architecture. Analysis included 2 early-onset colorectal cancer family trios and one quad consisting of two siblings with testicular cancer, all with unaffected parents. Structural variants (SVs), epigenetic profiles and single nucleotide variants (SNVs) were determined for each individual, and a filtering strategy was employed to refine and prioritize candidate variants based on the family architecture. The family architecture enabled us to focus on inapposite variants while filtering variants shared with the unaffected parents, significantly decreasing background variation that can hamper identification of potentially disease causing differences. Candidate de novo and compound heterozygous variants were identified in this way. Gene expression, in matched neoplastic and pre-neoplastic lesions, was assessed for one trio. Our study demonstrates the feasibility of a streamlined analysis of genomic variants from long read ONT whole genome sequencing and a way to prioritize key variants for further evaluation of pathogenicity, while revealing what may be missing from panel based analyses.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prevalence of Pathogenic Germline Variants in Cancer Susceptibility Genes using the All of Us Dataset
Gideon Idumah, Daphne Newell, … Joshua Arbesman·medRxiv·Mar 28, 2025
- Prevalence and Clinical Significance of Adult-Onset Cancer Predisposition Variants in Pediatric Oncology
Jamie L. Maciaszek, Victor Pastor Loyola, … Mohammad K. Eldomery·medRxiv·Jun 8, 2026
- Diverse mediators of cancer predisposition uncovered by germline whole genome sequencing of unexplained familial cancers
Noah Fields, Seunghun Han, … Eliezer M. Van Allen·medRxiv·May 13, 2026
- Inherited genetic risk factors in young-onset lung cancer
Myvizhi Esai Selvan, Bonnie E. Gould Rothberg, … Zeynep Hulya Gumus·medRxiv·Apr 15, 2026
- Family History Assessment Significantly Enhances Delivery of Precision Medicine in the Genomics Era
Yasmin M. Bylstra, Weng Khong Lim, … Patrick B. O. Tan·Genome MedicinePeer-reviewed·Jan 7, 2021
- Assessment of Genetic Susceptibility to Multiple Primary Cancers through Whole-Exome Sequencing in Two Large Multi-Ancestry Studies
Taylor B. Cavazos, Linda Kachuri, … John S. Witte·medRxiv·Feb 11, 2022